highly significantp < 0.0001
85.35 ± 9.50 mg/dL; NS), highly significant (p < 0.0001). drop in fasting insulin levels was observed; after the follow-up period of 6 months, fasting hyperinsulinemia was diagnosed only in 6 (15 %) patients.
85.35 ± 9.50 mg/dL; NS), highly significant (p < 0.0001). drop in fasting insulin levels was observed; after the follow-up period of 6 months, fasting hyperinsulinemia was diagnosed only in 6 (15 %) patients.